London & Chicago June 9th 2014 — The institutional trading community now has a new option for achieving the fastest access to market data from the CME Group, with today’s announcement of a new collaboration between Celoxica, a leading provider of ultra low-latency market data, order entry and pre-trade risk solutions and Born Technology, a premier provider of high-speed trading networks, managed hosting and sponsored access services.
The international collaboration addresses the growing need for a comprehensive ultra-low latency market access solution to enable firms to compete in today’s high-speed global markets. The partnership will unite Born Technology’s ultra-low latency infrastructure solutions and Celoxica’s hardware-accelerated market data and order execution gateways to provide institutional traders with the tools they need to execute extremely latency-sensitive trading strategies.
“This partnership enhances both companies’ core offerings and fits in perfectly with Celoxica’s strategic direction, to allow firms to focus on their trading strategies while reducing their costs,” said Celoxica CEO Jean-Marc Bouhelier. “We are excited to be working with Born to provide mutual clients with a robust, best of breed solution that offers them both the fastest, most reliable access to CME and a reduced time to market.”
The partnership will provide improved CME Group access to an institutional clientele, including global banks, hedge and futures fund managers, international brokers and proprietary trading firms.
“We are delighted to partner with Celoxica, a global leader in low-latency solutions,” said Born Technology President Derek Haworth. “Celoxica’s proven trading solutions will complement Born Technology’s infrastructure offering to better serve clients, as we continue to grow our global connectivity footprint. This aligns with our belief that faster connectivity and better execution benefits the trading community as a whole.”
Celoxica is a leading provider of hardware accelerated low-footprint, ultra low latency market data, order entry and risk trading solutions for the global financial services industry. Headquartered in the UK with offices in Chicago and New York, Celoxica delivers trading solutions to automated trading firms, banks and brokers seeking to optimize the performance of their trading applications across multiple asset classes in all market conditions, whilst reducing their total cost of ownership.
– ends –
For additional information on Celoxica, contact:
US Business Development, Celoxica
For additional information on Born, contact:
Executive Director, Born Technology
Press enquiries to:
Salli Roskilly Saffron Communications
t: +44 1763 208708